(Q40951070)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

review article

1 reference

title

Thrombolytic therapy. From myocardial to cerebral infarction. The MAST-I Group. Multicentre Acute Stroke Trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

multicenter clinical trial

18 October 2019

main subject

0 references

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

author name string

L Candelise

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

C Roncaglioni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

E Aritzu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

A Ciccone

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

publication date

1 February 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

Italian journal of neurological sciences

18 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

5-21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke.

18 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Spontaneous improvement after acute ischemic stroke. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Experimental thromboembolic stroke studied by positron emission tomography: immediate versus delayed reperfusion by fibrinolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Infarcts with a cardiac source of embolism in the NINDS Stroke Data Bank: neurologic examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Early computed tomographic findings for thrombolytic therapy in patients with acute brain embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Thrombolytic therapy in acute ischemic stroke. A Danish pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Delayed treatment with a t-PA analogue and streptokinase in a rabbit embolic stroke model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Hemorrhagic complications of thrombolytic therapy in experimental stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Tissue plasminogen activator in refractory unstable angina. A randomized double-blind placebo-controlled trial in patients with refractory unstable angina and subsequent angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Thrombolysis in acute ischemic stroke: does it work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01995705

Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 hours after onset of myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group

21 January 2018

1 reference

12 December 2020

PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome.

1 reference

12 December 2020

Very early thrombolytic therapy in suspected acute myocardial infarction. The Thrombolysis Early in Acute Heart Attack Trial Study Group

1 reference

12 December 2020

Thrombolytic therapy for thromboembolism of vertebrobasilar artery.

1 reference

12 December 2020

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoi

1 reference

12 December 2020

Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome. Results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase

1 reference

12 December 2020

ANTICOAGULANTS PLUS STREPTOKINASE THERAPY IN PROGRESSIVE STROKE

1 reference

12 December 2020

Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours.

1 reference

12 December 2020

Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence.

1 reference

12 December 2020

Thrombolysis in blocking of the internal carotid artery

1 reference

12 December 2020

Relevance of changes in blood fibrinolytic and coagulation parameters during thrombolytic therapy

1 reference

12 December 2020

Recombinant tissue plasminogen activator in two patients with basilar artery occlusion

1 reference

12 December 2020

Recombinant tissue-type plasminogen activator followed by heparin compared with heparin alone for refractory unstable angina pectoris.

1 reference

12 December 2020

Fibrinolytic therapy. Report on 5 year experience

1 reference

12 December 2020

Intravenous streptokinase in the management of a subset of patients with unstable angina: a randomized controlled trial

1 reference

12 December 2020

Coronary thrombosis: pathogenesis and clinical manifestations

1 reference

12 December 2020

Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?

1 reference

12 December 2020

Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors

1 reference

12 December 2020

Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction

1 reference

12 December 2020

Plasminogen Activator Italian Multicenter Study (PAIMS): comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-PA) with intravenous streptokinase in acute myocardial infarction

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)

1 reference

12 December 2020

Thrombolysis with recombinant human tissue-type plasminogen activator during instability in coronary artery disease: effect on myocardial ischemia and need for coronary revascularization. TRIC Study Group

1 reference

12 December 2020

Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction. ISIS (International Studies of Infarct Survival) pilot study

1 reference

12 December 2020

Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke

1 reference

12 December 2020

Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease

1 reference

12 December 2020

A randomized controlled trial of intravenous streptokinase in evolving acute myocardial infarction

1 reference

12 December 2020

Individual risk assessment for intracranial haemorrhage during thrombolytic therapy

1 reference

12 December 2020

Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator

1 reference

12 December 2020

Lysis of basilar artery occlusion with tissue plasminogen activator

1 reference

12 December 2020

Effects of urokinase and heparin on minimal cross-sectional area of the culprit narrowing in unstable angina pectoris

1 reference

12 December 2020

The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial

1 reference

12 December 2020

Streptokinase in the treatment of an acute cerebral embolus--a case report.

1 reference

12 December 2020

Transcranial Doppler sonography: anatomical landmarks and normal velocity values

1 reference

12 December 2020

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.

1 reference

12 December 2020

In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group

1 reference

12 December 2020

GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico

1 reference

12 December 2020

Tissue plasminogen activator reduces neurological damage after cerebral embolism.

1 reference

12 December 2020

Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected]

1 reference

12 December 2020

Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator

1 reference

12 December 2020

'Spectacular shrinking deficit': rapid recovery from a major hemispheric syndrome by migration of an embolus.

1 reference

12 December 2020

The beneficial effect of intracarotid urokinase on acute stroke in a baboon model

1 reference

12 December 2020

Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction

1 reference

12 December 2020

[Local fibrinolysis therapy in subtotal stenosis of the median cerebral artery]

1 reference

12 December 2020

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials

1 reference

12 December 2020

Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits

1 reference

12 December 2020

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

12 December 2020

An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction

1 reference

12 December 2020

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

1 reference

12 December 2020

Viability thresholds and the penumbra of focal ischemia

1 reference

12 December 2020

Local fibrinolytic therapy in ischemic carotid pathology

1 reference

12 December 2020

Bolus streptokinase after myocardial infarction

1 reference

12 December 2020

A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction

1 reference

12 December 2020

Thrombolytic intervention in acute thrombotic and embolic stroke

1 reference

12 December 2020

Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Randomised double-blind trial of recombinant pro-urokinase against streptokinase in acute myocardial infarction. PRIMI Trial Study Group

1 reference

12 December 2020

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

12 December 2020

Unanswered questions in thrombolysis

1 reference

12 December 2020

Transcranial Doppler sonography monitoring of local intra-arterial thrombolysis in acute occlusion of the middle cerebral artery

1 reference

12 December 2020

Fibrinolytic therapy of cerebral embolism with streptokinase. Case report

1 reference

12 December 2020

Cumulative meta-analysis of therapeutic trials for myocardial infarction

1 reference

12 December 2020

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct S

1 reference

12 December 2020

Local recombinant tissue plasminogen activator to clear cerebral artery thrombosis developing soon after surgery

1 reference

12 December 2020

The effects of a new tissue plasminogen activator analogue, Fb-Fb-CF, on cerebral reperfusion in a rabbit embolic stroke model

1 reference

12 December 2020

Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.

1 reference

12 December 2020

Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization

1 reference

12 December 2020

Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur) Collaborative Group

1 reference

12 December 2020

Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction

1 reference

12 December 2020

The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.

1 reference

12 December 2020

A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty

1 reference

12 December 2020

Vascular recanalizing techniques in interventional neuroradiology

1 reference

12 December 2020

Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group

1 reference

12 December 2020

Clinical effects and basic studies of thrombolytic therapy on cerebral thrombosis.

1 reference

12 December 2020

Thrombolytic therapy for stroke

1 reference

12 December 2020

Streptokinase in acute myocardial infarction. European Cooperative Study Group for Streptokinase Treatment in Acute Myocardial Infarction

1 reference

12 December 2020

Tissue plasminogen activator thrombolysis of a middle cerebral artery embolus in a patient with an arteriovenous malformation. Case report

1 reference

12 December 2020

The open-artery theory is alive and well--again

1 reference

12 December 2020

[Local fibrinolysis in basilar artery thrombosis (author's transl)]

1 reference

12 December 2020

Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke

1 reference

12 December 2020

Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo

1 reference

12 December 2020

Infusion of recombinant tissue plasminogen activator for treatment of basilar artery occlusion

1 reference

12 December 2020

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction

1 reference

12 December 2020

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

1 reference

12 December 2020

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

1 reference

12 December 2020

Putaminal haemorrhage after recanalization of an embolic MCA occlusion treated with tissue plasminogen activator

1 reference

12 December 2020

Local intraarterial fibrinolysis in the carotid territory.

1 reference

12 December 2020

Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease

1 reference

12 December 2020

Thrombolysis in acute myocardial infarction

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

12 December 2020

Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01995705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8742984%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference